PFIZER NORVASC CONTINUES STRONG GROWTH WITH U.S. SALES OF $785 MIL., UP 51% FOR 1996: JAMA STUDY SAYS CALCIUM CHANNEL BLOCKERS "OVERUSED" IN ELDERLY MI SURVIVORS